Ignite Creation Date:
2025-12-24 @ 11:50 PM
Ignite Modification Date:
2025-12-25 @ 9:44 PM
Study NCT ID:
NCT00896051
Status:
COMPLETED
Last Update Posted:
2013-09-30
First Post:
2009-05-07
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
TMC125-TiDP2-C238: An Exploratory Pharmacokinetics, Safety and Anti-HIV Activity Study of Etravirine (ETR) When Given With Boosted Atazanavir (ATV/Rtv) at Two Different Doses and 1 Nucleoside Reverse Transcriptase Inhibitor (NRTI) in Treatment Experienced HIV Patients
Sponsor:
Janssen R&D Ireland
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-08
Start Date Type:
None
Primary Completion Date:
2012-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-04
Completion Date Type:
ACTUAL
First Submit Date:
2009-05-07
First Submit QC Date:
None
Study First Post Date:
2009-05-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-04-10
Results First Submit QC Date:
None
Results First Post Date:
2013-09-30
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-09-27
Last Update Post Date:
2013-09-30
Last Update Post Date Type:
ESTIMATED